Guest guest Posted December 27, 2008 Report Share Posted December 27, 2008 A small phase II trial shows that Dutasteride (Avodart) does not pinical benefit to men with recurrent castrate resistant prostate cancer (www.advancedprostatecancer.net or http://www.ncbi.nlm.nih.gov/pubmed/19091347?dopt=Abstract) -- T NowakTo learn about the Petition to Make Prostate Cancer a National Priority go to http://www.prostatecancerpetition.org Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.